NCT05494099

Brief Summary

The aim of this study is to compare the outcomes of endoscopic middle meatus mega-antrostomy, endoscopic pre-lacrimal recess approach and endoscopic modified medial maxillectomy regarding: 1.Assessment of the accessibility of each approach to visualize and reach the different walls and recesses of the maxillary sinus. 2. Any intraoperative or postoperative complications. 3. Any post-operative recurrence or residue detected by endoscopic examination. 4. Symptomatic relief by pre- and post-operative Sino-Nasal Outcome Test 22, Arabic translation and validation (SNOT-22) which is a reliable and valid outcome measure for CRS patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 7, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 9, 2022

Completed
23 days until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

August 9, 2022

Status Verified

August 1, 2022

Enrollment Period

1.2 years

First QC Date

August 7, 2022

Last Update Submit

August 7, 2022

Conditions

Keywords

maxillary sinusendoscopic approaches

Outcome Measures

Primary Outcomes (1)

  • Intra-operative Endoscopic Assesment

    Assessment of the accessibility of endoscopic approach which will be evaluated by using different types of telescopes to visualize and reach the different walls and recesses of the maxillary sinus

    Intraoperative only

Secondary Outcomes (1)

  • Sino-Nasal Outcome Test 22,. Arabic translation and validation (SNOT-22)

    3 months

Study Arms (3)

Group A (1st 25 patients)

The middle meatal mega-antrostomy approach.

Procedure: endoscopic maxillary mega-antrostomy

Group B (2nd 25 patients)

The endoscopic modified medial maxillectomy approach.

Procedure: Endoscopic Modified Medial Maxillectomy

Group C (3rd 25 patients)

The endoscopic prelacrimal recess approach.

Procedure: Modified endoscopic pre-lacrimal approach

Interventions

a mucosal sparing technique that facilitates mucus clearance and sinus irrigation in terminally dysfunctional maxillary sinuses. EMMA involves extending the antrostomy through the posterior half of the inferior turbinate down to the floor of the nose, creating a significantly enlarged antrostomy.

Group A (1st 25 patients)

In this approach, the maxillary sinus is operated upon, while the inferior turbinate and nasolacrimal duct are preserved.

Group B (2nd 25 patients)

The approach involves making a curved mucosal incision on the lateral nasal wall just anterior to the head of the inferior turbinate. The nasal mucosa was then undermined off the lateral nasal wall. The maxillary sinus was entered with a chisel, and the medial bony wall of the maxillary sinus removed.

Group C (3rd 25 patients)

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with chronic rhinosinusitis who not respond to medical treatment and are planned to be operated by endoscopic sinus surgery.

You may qualify if:

  • Inflammatory disease of the maxillary sinus in the context of allergic or infective rhinosinusitis, with or without formation of inflammatory polyps. When such cases fail to respond to maximal medical therapy.
  • Benign and locally malignant neoplasms of the maxillary sinus (ex: inverted papilloma) which are planned to be removed by extended endoscopic approach.

You may not qualify if:

  • Patients who are unfit to surgery (ex: with bleeding disorders or severe systemic diseases).
  • Patients who refuse surgery or difficult to be followed up.
  • Patients with minimal lesions who respond to medical treatment.
  • Patients with malignant tumor of maxillary sinus proved by histopathology.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine

Tanta, Gharbia Government, Egypt

RECRUITING

Related Publications (11)

  • Goudakos JK, Blioskas S, Nikolaou A, Vlachtsis K, Karkos P, Markou KD. Endoscopic Resection of Sinonasal Inverted Papilloma: Systematic Review and Meta-Analysis. Am J Rhinol Allergy. 2018 May;32(3):167-174. doi: 10.1177/1945892418765004. Epub 2018 Apr 12.

    PMID: 29649889BACKGROUND
  • Robey A, O'Brien EK, Leopold DA. Assessing current technical limitations in the small-hole endoscopic approach to the maxillary sinus. Am J Rhinol Allergy. 2010 Sep-Oct;24(5):396-401. doi: 10.2500/ajra.2010.24.3486.

    PMID: 21244743BACKGROUND
  • Cho DY, Hwang PH. Results of endoscopic maxillary mega-antrostomy in recalcitrant maxillary sinusitis. Am J Rhinol. 2008 Nov-Dec;22(6):658-62. doi: 10.2500/ajr.2008.22.3248.

    PMID: 19178809BACKGROUND
  • Woodworth BA, Parker RO, Schlosser RJ. Modified endoscopic medial maxillectomy for chronic maxillary sinusitis. Am J Rhinol. 2006 May-Jun;20(3):317-9. doi: 10.2500/ajr.2006.20.2850.

    PMID: 16871936BACKGROUND
  • Gosau M, Rink D, Driemel O, Draenert FG. Maxillary sinus anatomy: a cadaveric study with clinical implications. Anat Rec (Hoboken). 2009 Mar;292(3):352-4. doi: 10.1002/ar.20859.

    PMID: 19248167BACKGROUND
  • Sadeghi N, Al-Dhahri S, Manoukian JJ. Transnasal endoscopic medial maxillectomy for inverting papilloma. Laryngoscope. 2003 Apr;113(4):749-53. doi: 10.1097/00005537-200304000-00031.

    PMID: 12671441BACKGROUND
  • Wormald PJ, Ooi E, van Hasselt CA, Nair S. Endoscopic removal of sinonasal inverted papilloma including endoscopic medial maxillectomy. Laryngoscope. 2003 May;113(5):867-73. doi: 10.1097/00005537-200305000-00017.

    PMID: 12792324BACKGROUND
  • Luong A, Citardi MJ, Batra PS. Management of sinonasal malignant neoplasms: defining the role of endoscopy. Am J Rhinol Allergy. 2010 Mar-Apr;24(2):150-5. doi: 10.2500/ajra.2010.24.3451.

    PMID: 20338116BACKGROUND
  • Kastl KG, Rettinger G, Keck T. The impact of nasal surgery on air-conditioning of the nasal airways. Rhinology. 2009 Sep;47(3):237-41. doi: 10.4193/Rhin08.014.

    PMID: 19839243BACKGROUND
  • Dayal A, Rhee JS, Garcia GJ. Impact of Middle versus Inferior Total Turbinectomy on Nasal Aerodynamics. Otolaryngol Head Neck Surg. 2016 Sep;155(3):518-25. doi: 10.1177/0194599816644915. Epub 2016 May 10.

    PMID: 27165673BACKGROUND
  • Morrissey DK, Wormald PJ, Psaltis AJ. Prelacrimal approach to the maxillary sinus. Int Forum Allergy Rhinol. 2016 Feb;6(2):214-8. doi: 10.1002/alr.21640. Epub 2015 Sep 8. No abstract available.

    PMID: 26346189BACKGROUND

Study Officials

  • Hassan Mu Hegazy, MD

    Tanta University Hospital, Egypt.

    STUDY DIRECTOR
  • Ahmed Mo Gamea, MD

    Tanta University Hospital, Egypt.

    STUDY DIRECTOR
  • Mohamed Os Tomom, MD

    Tanta University Hospital, Egypt.

    STUDY DIRECTOR

Central Study Contacts

Eslam mo Shata, MSc

CONTACT

Mohamed Ha Askar, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

August 7, 2022

First Posted

August 9, 2022

Study Start

September 1, 2022

Primary Completion

November 1, 2023

Study Completion

January 1, 2024

Last Updated

August 9, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will share

To compare the outcomes of endoscopic middle meatus mega-antrostomy, endoscopic pre-lacrimal recess approach and endoscopic modified medial maxillectomy regarding: 1.Assessment of the accessibility of each approach to visualize and reach the different walls and recesses of the maxillary sinus. 2. Any intraoperative or postoperative complications. 3. Any post-operative recurrence or residue detected by endoscopic examination. 4. Symptomatic relief by pre- and post-operative SNOT-22 which is a reliable and valid outcome measure for CRS patients.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
1 year

Locations